🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-03-18
Trial ID
NCT04837716
Treatments Being Tested
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
The PREOPANC-3 study is a randomized, multicenter, phase 3 trial. Patients ...
Status
Active Not Recruiting
Location
Jeroen Bosch Hospital
Start Date
2021-09-07
Trial ID
NCT04927780
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as carboplatin, thiotepa, and e...
Status
Completed
Location
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Start Date
2004-10
Trial ID
NCT00078988
This randomized phase III trial studies carboplatin given together with pac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2010-10-12
Trial ID
NCT01081262
Phase II trial to study the effectiveness of combination chemotherapy and p...
Status
Terminated
Location
Gynecologic Oncology Group
Start Date
1999-11
Trial ID
NCT00004221
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
The purpose of this trial is to compare the 3-year disease-free survival of...
Status
Unknown
Location
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2019-02-22
Trial ID
NCT03876886
Treatments Being Tested
To compare the objective response rate (ORR) and safety of tislelizumab com...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT05628610